FMC vs MNPR · rev $1.22B vs $431.4M cap
FMC Corporation (FMC) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported FMC revenue for 2024-12-31 was $1.22B. Net income was -$16.1M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. FMC currently screens at market cap $1.50B.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
FMC currently screens at market cap $1.50B. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the FMC and MNPR stock pages for the full models.
Not investment advice.